IMP
Process View
negative regulation of lipid metabolic process
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways involving lipids.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of lipid metabolic process"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| RELA | v-rel reticuloendotheliosis viral oncogene homolog A (avian) | 1.000 | Human | |
| APOA1 | apolipoprotein A-I | 0.995 | Human | |
| PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.982 | ||
| AKR1C2 | aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III) | 0.974 | Human | |
| ALB | albumin | 0.967 | ||
| REL | v-rel reticuloendotheliosis viral oncogene homolog (avian) | 0.962 | Human | |
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.958 | ||
| IL1R1 | interleukin 1 receptor, type I | 0.949 | ||
| AKR1C1 | aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase) | 0.948 | Human | |
| PPP2CA | protein phosphatase 2, catalytic subunit, alpha isozyme | 0.941 | ||
| PPP2R5C | protein phosphatase 2, regulatory subunit B', gamma | 0.939 | Human | |
| APOE | apolipoprotein E | 0.853 | ||
| VEGFA | vascular endothelial growth factor A | 0.802 | Human | |
| PPP2R1B | protein phosphatase 2, regulatory subunit A, beta | 0.743 | ||
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.742 | ||
| PPP2R5A | protein phosphatase 2, regulatory subunit B', alpha | 0.718 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.714 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.650 | ||
| NOXA1 | NADPH oxidase activator 1 | 0.644 | ||
| NFKB1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 | 0.620 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.614 | ||
| MPDZ | multiple PDZ domain protein | 0.593 | ||
| IER3 | immediate early response 3 | 0.586 | ||
| LDLR | low density lipoprotein receptor | 0.573 | ||
| MAGI2 | membrane associated guanylate kinase, WW and PDZ domain containing 2 | 0.554 | ||
| NCOR2 | nuclear receptor corepressor 2 | 0.544 | ||
| AKR1C3 | aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) | 0.527 | ||
| HNF4A | hepatocyte nuclear factor 4, alpha | 0.516 | ||
| NFKB2 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 (p49/p100) | 0.513 | Human | |
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.494 | ||
| PPP2R2A | protein phosphatase 2, regulatory subunit B, alpha | 0.433 | ||
| ACACA | acetyl-CoA carboxylase alpha | 0.411 | ||
| APOC1 | apolipoprotein C-I | 0.402 | ||
| HP | haptoglobin | 0.397 | ||
| NFKBIE | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, epsilon | 0.382 | ||
| ITGB1BP3 | integrin beta 1 binding protein 3 | 0.375 | ||
| IL1RAP | interleukin 1 receptor accessory protein | 0.301 | ||
| CDCP1 | CUB domain containing protein 1 | 0.278 | ||
| IKBKG | inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma | 0.269 | ||
| APOC3 | apolipoprotein C-III | 0.257 | ||
| ESR1 | estrogen receptor 1 | 0.246 | Rat | |
| AKT1 | v-akt murine thymoma viral oncogene homolog 1 | 0.239 | ||
| RXRA | retinoid X receptor, alpha | 0.231 | ||
| ATF4 | activating transcription factor 4 (tax-responsive enhancer element B67) | 0.220 | ||
| PICK1 | protein interacting with PRKCA 1 | 0.219 | ||
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.217 | ||
| PPP2R1A | protein phosphatase 2, regulatory subunit A, alpha | 0.203 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.191 | ||
| CREB1 | cAMP responsive element binding protein 1 | 0.180 | ||
| HR | hairless homolog (mouse) | 0.179 | ||
| MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.172 | ||
| APOC2 | apolipoprotein C-II | 0.162 | ||
| CREBBP | CREB binding protein | 0.161 | ||
| PGF | placental growth factor | 0.161 | Human | |
| CYP51A1 | cytochrome P450, family 51, subfamily A, polypeptide 1 | 0.159 | ||
| APOA2 | apolipoprotein A-II | 0.154 | ||
| HMGCR | 3-hydroxy-3-methylglutaryl-CoA reductase | 0.151 | ||
| LATS2 | LATS, large tumor suppressor, homolog 2 (Drosophila) | 0.149 | ||
| RARA | retinoic acid receptor, alpha | 0.146 | ||
| KLB | klotho beta | 0.143 | ||
| JUB | jub, ajuba homolog (Xenopus laevis) | 0.138 | ||
| TRADD | TNFRSF1A-associated via death domain | 0.135 | ||
| PPP2R5E | protein phosphatase 2, regulatory subunit B', epsilon isoform | 0.133 | Human | |
| CCDC6 | coiled-coil domain containing 6 | 0.128 | ||
| BCL2 | B-cell CLL/lymphoma 2 | 0.128 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.126 | ||
| TNFRSF1A | tumor necrosis factor receptor superfamily, member 1A | 0.126 | ||
| SESN2 | sestrin 2 | 0.124 | ||
| ATF5 | activating transcription factor 5 | 0.115 | ||
| PRKAB1 | protein kinase, AMP-activated, beta 1 non-catalytic subunit | 0.099 | ||
| APOB | apolipoprotein B (including Ag(x) antigen) | 0.091 | ||
| HMGCS1 | 3-hydroxy-3-methylglutaryl-CoA synthase 1 (soluble) | 0.091 | ||
| PPFIA1 | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1 | 0.091 | ||
| CSNK1A1 | casein kinase 1, alpha 1 | 0.090 | ||
| FGA | fibrinogen alpha chain | 0.089 | ||
| IL1R2 | interleukin 1 receptor, type II | 0.088 | ||
| IDI1 | isopentenyl-diphosphate delta isomerase 1 | 0.088 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.083 | ||
| IL1B | interleukin 1, beta | 0.078 | ||
| A2M | alpha-2-macroglobulin | 0.075 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.074 | ||
| MAP3K8 | mitogen-activated protein kinase kinase kinase 8 | 0.073 | ||
| PPP2R5D | protein phosphatase 2, regulatory subunit B', delta | 0.072 | Human | |
| WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.072 | ||
| EP300 | E1A binding protein p300 | 0.071 | ||
| ADORA2A | adenosine A2a receptor | 0.070 | ||
| AHSG | alpha-2-HS-glycoprotein | 0.069 | ||
| FGF18 | fibroblast growth factor 18 | 0.068 | ||
| CHUK | conserved helix-loop-helix ubiquitous kinase | 0.066 | ||
| RASGRF1 | Ras protein-specific guanine nucleotide-releasing factor 1 | 0.065 | ||
| ARRDC3 | arrestin domain containing 3 | 0.065 | ||
| TF | transferrin | 0.065 | ||
| LCAT | lecithin-cholesterol acyltransferase | 0.064 | ||
| BAG3 | BCL2-associated athanogene 3 | 0.061 | ||
| PDK1 | pyruvate dehydrogenase kinase, isozyme 1 | 0.061 | ||
| TNIP2 | TNFAIP3 interacting protein 2 | 0.057 | ||
| RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.056 | ||
| BMP4 | bone morphogenetic protein 4 | 0.056 | Human | |
| WNT11 | wingless-type MMTV integration site family, member 11 | 0.056 | Human | |
| NRP1 | neuropilin 1 | 0.055 | ||
| TSC22D1 | TSC22 domain family, member 1 | 0.054 | ||
| SREBF2 | sterol regulatory element binding transcription factor 2 | 0.053 | ||
| PRKCZ | protein kinase C, zeta | 0.052 | Human | |
| DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | 0.052 | ||
| TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.051 | ||
| ITCH | itchy E3 ubiquitin protein ligase homolog (mouse) | 0.050 | ||
| TRAF1 | TNF receptor-associated factor 1 | 0.050 | ||
| ZHX1 | zinc fingers and homeoboxes 1 | 0.049 | ||
| NFKBIA | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | 0.047 | ||
| TNFRSF1B | tumor necrosis factor receptor superfamily, member 1B | 0.045 | ||
| IGF2R | insulin-like growth factor 2 receptor | 0.044 | ||
| EGR1 | early growth response 1 | 0.044 | ||
| SH3RF1 | SH3 domain containing ring finger 1 | 0.043 | ||
| CXCL14 | chemokine (C-X-C motif) ligand 14 | 0.043 | ||
| NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.043 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.043 | ||
| SOCS1 | suppressor of cytokine signaling 1 | 0.042 | ||
| IL1RN | interleukin 1 receptor antagonist | 0.042 | Human | |
| CHEK2 | CHK2 checkpoint homolog (S. pombe) | 0.042 | ||
| AQP7 | aquaporin 7 | 0.041 | ||
| CCL20 | chemokine (C-C motif) ligand 20 | 0.041 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.041 | ||
| IHH | Indian hedgehog | 0.040 | ||
| RCOR1 | REST corepressor 1 | 0.040 | ||
| NR5A2 | nuclear receptor subfamily 5, group A, member 2 | 0.039 | ||
| MAPT | microtubule-associated protein tau | 0.039 | ||
| PPP5C | protein phosphatase 5, catalytic subunit | 0.039 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.038 | ||
| SFRP1 | secreted frizzled-related protein 1 | 0.038 | ||
| SQLE | squalene epoxidase | 0.037 | ||
| SCRT1 | scratch homolog 1, zinc finger protein (Drosophila) | 0.037 | Human | |
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.037 | Human | |
| TBL1XR1 | transducin (beta)-like 1 X-linked receptor 1 | 0.036 | ||
| MMP11 | matrix metallopeptidase 11 (stromelysin 3) | 0.036 | ||
| FGF4 | fibroblast growth factor 4 | 0.036 | ||
| WNT1 | wingless-type MMTV integration site family, member 1 | 0.035 | Human | |
| MED25 | mediator complex subunit 25 | 0.035 | ||
| NBN | nibrin | 0.035 | ||
| PRKCA | protein kinase C, alpha | 0.035 | ||
| RICTOR | RPTOR independent companion of MTOR, complex 2 | 0.034 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.033 | ||
| PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.033 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.032 | ||
| NCOR1 | nuclear receptor corepressor 1 | 0.031 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.031 | ||
| PCK1 | phosphoenolpyruvate carboxykinase 1 (soluble) | 0.031 | ||
| PRKCB | protein kinase C, beta | 0.031 | ||
| NOG | noggin | 0.031 | ||
| NDUFA1 | NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa | 0.031 | ||
| TP73 | tumor protein p73 | 0.031 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.030 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.030 | ||
| HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.029 | ||
| TNFRSF10C | tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain | 0.029 | ||
| CCNG2 | cyclin G2 | 0.029 | ||
| PPP1CB | protein phosphatase 1, catalytic subunit, beta isozyme | 0.029 | ||
| HTR1A | 5-hydroxytryptamine (serotonin) receptor 1A | 0.029 | Human | |
| KCNA1 | potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) | 0.029 | ||
| JAG2 | jagged 2 | 0.029 | ||
| APOA4 | apolipoprotein A-IV | 0.029 | ||
| FDFT1 | farnesyl-diphosphate farnesyltransferase 1 | 0.029 | ||
| APOC4 | apolipoprotein C-IV | 0.029 | ||
| SOD3 | superoxide dismutase 3, extracellular | 0.028 | ||
| FGF8 | fibroblast growth factor 8 (androgen-induced) | 0.028 | ||
| SC4MOL | sterol-C4-methyl oxidase-like | 0.027 | ||
| SPRR2A | small proline-rich protein 2A | 0.027 | ||
| PNPLA2 | patatin-like phospholipase domain containing 2 | 0.026 | ||
| SMARCB1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | 0.026 | ||
| GAD2 | glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) | 0.026 | ||
| F7 | coagulation factor VII (serum prothrombin conversion accelerator) | 0.026 | ||
| RUNX1 | runt-related transcription factor 1 | 0.026 | ||
| THRA | thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian) | 0.026 | ||
| ARHGEF2 | Rho/Rac guanine nucleotide exchange factor (GEF) 2 | 0.025 | ||
| FHOD3 | formin homology 2 domain containing 3 | 0.025 | ||
| CFTR | cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7) | 0.025 | ||
| PDGFC | platelet derived growth factor C | 0.025 | ||
| NELL2 | NEL-like 2 (chicken) | 0.024 | ||
| SOX21 | SRY (sex determining region Y)-box 21 | 0.024 | ||
| NOV | nephroblastoma overexpressed gene | 0.024 | ||
| TNFRSF9 | tumor necrosis factor receptor superfamily, member 9 | 0.024 | ||
| PLIN1 | perilipin 1 | 0.024 | ||
| DLG4 | discs, large homolog 4 (Drosophila) | 0.024 | ||
| COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) | 0.024 | ||
| WNT4 | wingless-type MMTV integration site family, member 4 | 0.024 | ||
| GSK3B | glycogen synthase kinase 3 beta | 0.024 | ||
| PRDM5 | PR domain containing 5 | 0.024 | ||
| GJD2 | gap junction protein, delta 2, 36kDa | 0.024 | ||
| NR1H3 | nuclear receptor subfamily 1, group H, member 3 | 0.023 | ||
| HTR1D | 5-hydroxytryptamine (serotonin) receptor 1D | 0.023 | Human | |
| CALCOCO1 | calcium binding and coiled-coil domain 1 | 0.023 | ||
| BMP8A | bone morphogenetic protein 8a | 0.023 | Human | |
| HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B | 0.023 | Human | |
| CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.022 | ||
| TG | thyroglobulin | 0.022 | ||
| ADH1A | alcohol dehydrogenase 1A (class I), alpha polypeptide | 0.022 | ||
| CCL1 | chemokine (C-C motif) ligand 1 | 0.022 | ||
| LCK | lymphocyte-specific protein tyrosine kinase | 0.022 | ||
| RBL2 | retinoblastoma-like 2 (p130) | 0.022 | ||
| PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | 0.022 | ||
| SMARCC2 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2 | 0.022 | ||
| BMPR1B | bone morphogenetic protein receptor, type IB | 0.022 | ||
| DZIP1 | DAZ interacting protein 1 | 0.022 | ||
| SCD | stearoyl-CoA desaturase (delta-9-desaturase) | 0.022 | ||
| EIF4E | eukaryotic translation initiation factor 4E | 0.021 | ||
| CIDEA | cell death-inducing DFFA-like effector a | 0.021 | ||
| PDPK1 | 3-phosphoinositide dependent protein kinase-1 | 0.021 | ||
| CCL14 | chemokine (C-C motif) ligand 14 | 0.021 | ||
| STARD4 | StAR-related lipid transfer (START) domain containing 4 | 0.021 | ||
| AADAC | arylacetamide deacetylase (esterase) | 0.021 | ||
| PDE1B | phosphodiesterase 1B, calmodulin-dependent | 0.021 | ||
| SNIP1 | Smad nuclear interacting protein 1 | 0.021 | ||
| BHLHE40 | basic helix-loop-helix family, member e40 | 0.021 | ||
| ARRB1 | arrestin, beta 1 | 0.021 | ||
| DCN | decorin | 0.021 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.021 | ||
| ALDOB | aldolase B, fructose-bisphosphate | 0.021 | ||
| PPARA | peroxisome proliferator-activated receptor alpha | 0.020 | Human | |
| WIF1 | WNT inhibitory factor 1 | 0.020 | ||
| HTR6 | 5-hydroxytryptamine (serotonin) receptor 6 | 0.020 | ||
| FANCD2 | Fanconi anemia, complementation group D2 | 0.020 | ||
| FGF3 | fibroblast growth factor 3 | 0.020 | ||
| MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0.020 | ||
| COPG2 | coatomer protein complex, subunit gamma 2 | 0.020 | ||
| NCOA1 | nuclear receptor coactivator 1 | 0.020 | ||
| SOCS3 | suppressor of cytokine signaling 3 | 0.019 | ||
| KDM1A | lysine (K)-specific demethylase 1A | 0.019 | ||
| IL8 | interleukin 8 | 0.019 | ||
| MTOR | mechanistic target of rapamycin (serine/threonine kinase) | 0.019 | ||
| ADH1B | alcohol dehydrogenase 1B (class I), beta polypeptide | 0.019 | ||
| A1CF | APOBEC1 complementation factor | 0.019 | ||
| ZNF71 | zinc finger protein 71 | 0.019 | ||
| PTEN | phosphatase and tensin homolog | 0.019 | ||
| PALM | paralemmin | 0.019 | ||
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.019 | ||
| FOXF2 | forkhead box F2 | 0.019 | ||
| GADD45G | growth arrest and DNA-damage-inducible, gamma | 0.019 | ||
| RARRES2 | retinoic acid receptor responder (tazarotene induced) 2 | 0.019 | ||
| PARD6B | par-6 partitioning defective 6 homolog beta (C. elegans) | 0.019 | ||
| PRKAG1 | protein kinase, AMP-activated, gamma 1 non-catalytic subunit | 0.019 | ||
| NPY2R | neuropeptide Y receptor Y2 | 0.018 | ||
| DDIT4 | DNA-damage-inducible transcript 4 | 0.018 | ||
| PPP2R2C | protein phosphatase 2, regulatory subunit B, gamma | 0.018 | ||
| ZMYND11 | zinc finger, MYND-type containing 11 | 0.018 | ||
| BAI1 | brain-specific angiogenesis inhibitor 1 | 0.018 | ||
| SLC10A2 | solute carrier family 10 (sodium/bile acid cotransporter family), member 2 | 0.018 | ||
| PTGER3 | prostaglandin E receptor 3 (subtype EP3) | 0.018 | ||
| F2 | coagulation factor II (thrombin) | 0.018 | ||
| PPP2R5B | protein phosphatase 2, regulatory subunit B', beta | 0.018 | Human | |
| FABP4 | fatty acid binding protein 4, adipocyte | 0.018 | ||
| AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | 0.018 | ||
| SGOL1 | shugoshin-like 1 (S. pombe) | 0.018 | ||
| LIPC | lipase, hepatic | 0.018 | ||
| UCP1 | uncoupling protein 1 (mitochondrial, proton carrier) | 0.017 | ||
| HTR7 | 5-hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled) | 0.017 | ||
| SLC2A4 | solute carrier family 2 (facilitated glucose transporter), member 4 | 0.017 | ||
| ADH1C | alcohol dehydrogenase 1C (class I), gamma polypeptide | 0.017 | ||
| SIN3A | SIN3 homolog A, transcription regulator (yeast) | 0.017 | ||
| STC1 | stanniocalcin 1 | 0.017 | ||
| TSHR | thyroid stimulating hormone receptor | 0.017 | ||
| TICAM2 | toll-like receptor adaptor molecule 2 | 0.017 | ||
| CD83 | CD83 molecule | 0.017 | ||
| DPT | dermatopontin | 0.017 | ||
| MFN1 | mitofusin 1 | 0.017 | ||
| ABCA6 | ATP-binding cassette, sub-family A (ABC1), member 6 | 0.017 | ||
| AMBP | alpha-1-microglobulin/bikunin precursor | 0.017 | ||
| RPS6KB1 | ribosomal protein S6 kinase, 70kDa, polypeptide 1 | 0.017 | ||
| REG3A | regenerating islet-derived 3 alpha | 0.017 | ||
| PTGIS | prostaglandin I2 (prostacyclin) synthase | 0.017 | ||
| THPO | thrombopoietin | 0.017 | ||
| AXIN1 | axin 1 | 0.017 | ||
| WISP2 | WNT1 inducible signaling pathway protein 2 | 0.017 | ||
| CALCR | calcitonin receptor | 0.016 | ||
| LOXL4 | lysyl oxidase-like 4 | 0.016 | ||
| TAL1 | T-cell acute lymphocytic leukemia 1 | 0.016 | ||
| NTRK3 | neurotrophic tyrosine kinase, receptor, type 3 | 0.016 | ||
| PRDX1 | peroxiredoxin 1 | 0.016 | ||
| SLC7A10 | solute carrier family 7, (neutral amino acid transporter, y+ system) member 10 | 0.016 | ||
| ACAA1 | acetyl-CoA acyltransferase 1 | 0.016 | ||
| ROR2 | receptor tyrosine kinase-like orphan receptor 2 | 0.016 | ||
| STC2 | stanniocalcin 2 | 0.016 | ||
| KLK13 | kallikrein-related peptidase 13 | 0.016 | ||
| NDRG1 | N-myc downstream regulated 1 | 0.016 | ||
| IL32 | interleukin 32 | 0.016 | ||
| WNT6 | wingless-type MMTV integration site family, member 6 | 0.016 | Human | |
| TM4SF4 | transmembrane 4 L six family member 4 | 0.016 | ||
| PPME1 | protein phosphatase methylesterase 1 | 0.016 | ||
| FNIP1 | folliculin interacting protein 1 | 0.016 | ||
| CHRNA4 | cholinergic receptor, nicotinic, alpha 4 | 0.016 | ||
| CHD9 | chromodomain helicase DNA binding protein 9 | 0.015 | ||
| UFM1 | ubiquitin-fold modifier 1 | 0.015 | ||
| CSF2 | colony stimulating factor 2 (granulocyte-macrophage) | 0.015 | ||
| GUCA2A | guanylate cyclase activator 2A (guanylin) | 0.015 | ||
| MAP1LC3A | microtubule-associated protein 1 light chain 3 alpha | 0.015 | ||
| PTHLH | parathyroid hormone-like hormone | 0.015 | ||
| DRD1 | dopamine receptor D1 | 0.015 | Human | |
| BMP8B | bone morphogenetic protein 8b | 0.015 | Human | |
| EGR3 | early growth response 3 | 0.015 | ||
| KCNMA1 | potassium large conductance calcium-activated channel, subfamily M, alpha member 1 | 0.015 | ||
| SORBS3 | sorbin and SH3 domain containing 3 | 0.015 | ||
| GRIK3 | glutamate receptor, ionotropic, kainate 3 | 0.015 | ||
| BAAT | bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) | 0.015 | ||
| FOXF1 | forkhead box F1 | 0.015 | ||
| GDF6 | growth differentiation factor 6 | 0.015 | Human | |
| NXPH3 | neurexophilin 3 | 0.015 | ||
| PARD6G | par-6 partitioning defective 6 homolog gamma (C. elegans) | 0.015 | ||
| EFNB3 | ephrin-B3 | 0.015 | ||
| NPY5R | neuropeptide Y receptor Y5 | 0.015 | ||
| PTPN5 | protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) | 0.015 | ||
| FGFR4 | fibroblast growth factor receptor 4 | 0.015 | ||
| COL14A1 | collagen, type XIV, alpha 1 | 0.015 | ||
| G0S2 | G0/G1switch 2 | 0.015 | ||
| FZD10 | frizzled homolog 10 (Drosophila) | 0.015 | ||
| ADRA2B | adrenergic, alpha-2B-, receptor | 0.014 | ||
| TNXB | tenascin XB | 0.014 | ||
| FZD4 | frizzled homolog 4 (Drosophila) | 0.014 | ||
| ETF1 | eukaryotic translation termination factor 1 | 0.014 | ||
| RARG | retinoic acid receptor, gamma | 0.014 | ||
| P2RY1 | purinergic receptor P2Y, G-protein coupled, 1 | 0.014 | ||
| FABP1 | fatty acid binding protein 1, liver | 0.014 | ||
| F10 | coagulation factor X | 0.014 | ||
| ABCG5 | ATP-binding cassette, sub-family G (WHITE), member 5 | 0.014 | ||
| SVEP1 | sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1 | 0.014 | ||
| OLIG2 | oligodendrocyte lineage transcription factor 2 | 0.014 | ||
| DTX1 | deltex homolog 1 (Drosophila) | 0.014 | ||
| MASP1 | mannan-binding lectin serine peptidase 1 (C4/C2 activating component of Ra-reactive factor) | 0.014 | ||
| WNT2 | wingless-type MMTV integration site family member 2 | 0.014 | Human | |
| PCK2 | phosphoenolpyruvate carboxykinase 2 (mitochondrial) | 0.014 | ||
| SLC6A4 | solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 | 0.014 | ||
| CFB | complement factor B | 0.014 | ||
| CRAT | carnitine O-acetyltransferase | 0.014 | ||
| HMX1 | H6 family homeobox 1 | 0.014 | ||
| INHBB | inhibin, beta B | 0.014 | ||
| LBP | lipopolysaccharide binding protein | 0.014 | ||
| BMP6 | bone morphogenetic protein 6 | 0.014 | Human | |
| UGT1A9 | UDP glucuronosyltransferase 1 family, polypeptide A9 | 0.014 | ||
| ZFPM1 | zinc finger protein, multitype 1 | 0.014 | ||
| RRN3 | RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae) | 0.014 | ||
| TNFSF9 | tumor necrosis factor (ligand) superfamily, member 9 | 0.014 | ||
| CDX2 | caudal type homeobox 2 | 0.014 | ||
| DHCR7 | 7-dehydrocholesterol reductase | 0.014 | ||
| ADRB3 | adrenergic, beta-3-, receptor | 0.014 | Human | |
| STK11 | serine/threonine kinase 11 | 0.014 | ||
| NPPC | natriuretic peptide C | 0.013 | ||
| POFUT1 | protein O-fucosyltransferase 1 | 0.013 | ||
| CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.013 | ||
| CSNK1E | casein kinase 1, epsilon | 0.013 | ||
| TTR | transthyretin | 0.013 | ||
| CREBZF | CREB/ATF bZIP transcription factor | 0.013 | ||
| PPP2R3B | protein phosphatase 2, regulatory subunit B'', beta | 0.013 | ||
| SCARB1 | scavenger receptor class B, member 1 | 0.013 | ||
| IL4R | interleukin 4 receptor | 0.013 | ||
| ARG1 | arginase, liver | 0.013 | ||
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.013 | ||
| SERPINB2 | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 0.013 | ||
| INHBA | inhibin, beta A | 0.013 | ||
| AVPR1A | arginine vasopressin receptor 1A | 0.013 | ||
| NCOA3 | nuclear receptor coactivator 3 | 0.013 | ||
| CDC37 | cell division cycle 37 homolog (S. cerevisiae) | 0.013 | ||
| GPR6 | G protein-coupled receptor 6 | 0.013 | ||
| TRIM9 | tripartite motif containing 9 | 0.013 | ||
| HTR2C | 5-hydroxytryptamine (serotonin) receptor 2C | 0.013 | Human | |
| NR1I3 | nuclear receptor subfamily 1, group I, member 3 | 0.013 | Human | |
| MAG | myelin associated glycoprotein | 0.013 | ||
| IL6R | interleukin 6 receptor | 0.013 | ||
| ST8SIA2 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 | 0.013 | ||
| FGF17 | fibroblast growth factor 17 | 0.013 | ||
| SP1 | Sp1 transcription factor | 0.013 | ||
| CSNK1G3 | casein kinase 1, gamma 3 | 0.013 | ||
| APCS | amyloid P component, serum | 0.013 | ||
| TGFA | transforming growth factor, alpha | 0.013 | ||
| CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 | 0.013 | ||
| AR | androgen receptor | 0.013 | ||
| FAF1 | Fas (TNFRSF6) associated factor 1 | 0.013 | ||
| PCNP | PEST proteolytic signal containing nuclear protein | 0.013 | ||
| GDNF | glial cell derived neurotrophic factor | 0.013 | ||
| PITX2 | paired-like homeodomain 2 | 0.013 | ||
| PAX1 | paired box 1 | 0.013 | ||
| POR | P450 (cytochrome) oxidoreductase | 0.013 | ||
| HAND1 | heart and neural crest derivatives expressed 1 | 0.012 | ||
| RUNDC3A | RUN domain containing 3A | 0.012 | ||
| UGT1A10 | UDP glucuronosyltransferase 1 family, polypeptide A10 | 0.012 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.012 | ||
| ART4 | ADP-ribosyltransferase 4 (Dombrock blood group) | 0.012 | ||
| CYP26A1 | cytochrome P450, family 26, subfamily A, polypeptide 1 | 0.012 | ||
| CDH7 | cadherin 7, type 2 | 0.012 | ||
| GPRC5B | G protein-coupled receptor, family C, group 5, member B | 0.012 | ||
| ATXN3 | ataxin 3 | 0.012 | ||
| RAD50 | RAD50 homolog (S. cerevisiae) | 0.012 | ||
| ADIPOQ | adiponectin, C1Q and collagen domain containing | 0.012 | ||
| LSS | lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) | 0.012 | ||
| CYP3A43 | cytochrome P450, family 3, subfamily A, polypeptide 43 | 0.012 | ||
| DSCAML1 | Down syndrome cell adhesion molecule like 1 | 0.012 | ||
| FMR1 | fragile X mental retardation 1 | 0.012 | ||
| LOR | loricrin | 0.012 | ||
| HOXC8 | homeobox C8 | 0.012 | ||
| LECT1 | leukocyte cell derived chemotaxin 1 | 0.012 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.012 | ||
| COL4A4 | collagen, type IV, alpha 4 | 0.012 | ||
| ITGB1BP1 | integrin beta 1 binding protein 1 | 0.012 | ||
| PPP2R4 | protein phosphatase 2A activator, regulatory subunit 4 | 0.012 | ||
| NXPH4 | neurexophilin 4 | 0.012 | ||
| CARS | cysteinyl-tRNA synthetase | 0.012 | ||
| SLC38A3 | solute carrier family 38, member 3 | 0.012 | ||
| WT1 | Wilms tumor 1 | 0.012 | ||
| SNCG | synuclein, gamma (breast cancer-specific protein 1) | 0.012 | ||
| CA4 | carbonic anhydrase IV | 0.012 | ||
| TXNDC2 | thioredoxin domain containing 2 (spermatozoa) | 0.012 | ||
| THRAP3 | thyroid hormone receptor associated protein 3 | 0.012 | ||
| PBXIP1 | pre-B-cell leukemia homeobox interacting protein 1 | 0.012 | ||
| POU3F1 | POU class 3 homeobox 1 | 0.012 | ||
| RELN | reelin | 0.012 | ||
| CD40 | CD40 molecule, TNF receptor superfamily member 5 | 0.012 | ||
| PLTP | phospholipid transfer protein | 0.012 | ||
| NOTCH3 | notch 3 | 0.012 | ||
| FAM83C | family with sequence similarity 83, member C | 0.012 | ||
| CRHBP | corticotropin releasing hormone binding protein | 0.012 | ||
| HCRTR1 | hypocretin (orexin) receptor 1 | 0.012 | ||
| MCAM | melanoma cell adhesion molecule | 0.012 | ||
| NTN1 | netrin 1 | 0.012 | ||
| SMG1 | SMG1 homolog, phosphatidylinositol 3-kinase-related kinase (C. elegans) | 0.012 | ||
| NRCAM | neuronal cell adhesion molecule | 0.012 | ||
| SLC6A5 | solute carrier family 6 (neurotransmitter transporter, glycine), member 5 | 0.012 | ||
| MTTP | microsomal triglyceride transfer protein | 0.012 | ||
| SFRP4 | secreted frizzled-related protein 4 | 0.012 | ||
| ONECUT2 | one cut homeobox 2 | 0.012 | ||
| IL11 | interleukin 11 | 0.012 | ||
| PRELP | proline/arginine-rich end leucine-rich repeat protein | 0.012 | ||
| EGR2 | early growth response 2 | 0.012 | ||
| HS3ST2 | heparan sulfate (glucosamine) 3-O-sulfotransferase 2 | 0.012 | ||
| GLYAT | glycine-N-acyltransferase | 0.012 | ||
| HDAC3 | histone deacetylase 3 | 0.011 | ||
| HTR4 | 5-hydroxytryptamine (serotonin) receptor 4 | 0.011 | Human | |
| CCDC115 | coiled-coil domain containing 115 | 0.011 | ||
| MAT1A | methionine adenosyltransferase I, alpha | 0.011 | ||
| TNFAIP2 | tumor necrosis factor, alpha-induced protein 2 | 0.011 | ||
| IL1A | interleukin 1, alpha | 0.011 | Human | |
| ITIH5 | inter-alpha (globulin) inhibitor H5 | 0.011 | ||
| SOX1 | SRY (sex determining region Y)-box 1 | 0.011 | ||
| SLIT2 | slit homolog 2 (Drosophila) | 0.011 | ||
| KCNJ5 | potassium inwardly-rectifying channel, subfamily J, member 5 | 0.011 | ||
| ADRA1D | adrenergic, alpha-1D-, receptor | 0.011 | ||
| AGXT | alanine-glyoxylate aminotransferase | 0.011 | ||
| RGN | regucalcin (senescence marker protein-30) | 0.011 | ||
| CIDEC | cell death-inducing DFFA-like effector c | 0.011 | Human | |
| NFIX | nuclear factor I/X (CCAAT-binding transcription factor) | 0.011 | ||
| HYAL1 | hyaluronoglucosaminidase 1 | 0.011 | ||
| CRELD1 | cysteine-rich with EGF-like domains 1 | 0.011 | ||
| CYP4F12 | cytochrome P450, family 4, subfamily F, polypeptide 12 | 0.011 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.011 | ||
| IL6 | interleukin 6 (interferon, beta 2) | 0.011 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.011 | ||
| PNPLA3 | patatin-like phospholipase domain containing 3 | 0.011 | ||
| CCR9 | chemokine (C-C motif) receptor 9 | 0.011 | ||
| ABCC6 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 | 0.011 | ||
| LEP | leptin | 0.011 | ||
| GLI1 | GLI family zinc finger 1 | 0.011 | ||
| CCNE1 | cyclin E1 | 0.011 | ||
| RBCK1 | RanBP-type and C3HC4-type zinc finger containing 1 | 0.011 | ||
| FADS1 | fatty acid desaturase 1 | 0.011 | ||
| SLC35A3 | solute carrier family 35 (UDP-N-acetylglucosamine (UDP-GlcNAc) transporter), member A3 | 0.011 | ||
| RBP4 | retinol binding protein 4, plasma | 0.011 | ||
| KRT9 | keratin 9 | 0.011 | ||
| HRH3 | histamine receptor H3 | 0.011 | ||
| MAPK3 | mitogen-activated protein kinase 3 | 0.011 | ||
| C8B | complement component 8, beta polypeptide | 0.011 | ||
| GPC3 | glypican 3 | 0.011 | ||
| F3 | coagulation factor III (thromboplastin, tissue factor) | 0.011 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.011 | ||
| DMD | dystrophin | 0.011 | ||
| BMP7 | bone morphogenetic protein 7 | 0.011 | Human | |
| FOXC2 | forkhead box C2 (MFH-1, mesenchyme forkhead 1) | 0.011 | ||
| NLRC4 | NLR family, CARD domain containing 4 | 0.011 | ||
| SFRP2 | secreted frizzled-related protein 2 | 0.011 | ||
| COL4A6 | collagen, type IV, alpha 6 | 0.011 | ||
| HSD3B2 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | 0.011 | ||
| THRB | thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian) | 0.011 | ||
| FZD8 | frizzled homolog 8 (Drosophila) | 0.011 | ||
| SMARCD1 | SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1 | 0.011 | ||
| MAFF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 0.011 | ||
| BHMT | betaine--homocysteine S-methyltransferase | 0.011 | ||
| USHBP1 | Usher syndrome 1C binding protein 1 | 0.011 | ||
| IGFBP2 | insulin-like growth factor binding protein 2, 36kDa | 0.011 | ||
| EREG | epiregulin | 0.011 | ||
| AOC3 | amine oxidase, copper containing 3 (vascular adhesion protein 1) | 0.011 | ||
| WNT7A | wingless-type MMTV integration site family, member 7A | 0.011 | Human | |
| USH1C | Usher syndrome 1C (autosomal recessive, severe) | 0.011 | ||
| ATF1 | activating transcription factor 1 | 0.011 | ||
| KNG1 | kininogen 1 | 0.011 | ||
| SRCIN1 | SRC kinase signaling inhibitor 1 | 0.011 | ||
| ITIH1 | inter-alpha (globulin) inhibitor H1 | 0.011 | ||
| OTC | ornithine carbamoyltransferase | 0.011 | ||
| HGFAC | HGF activator | 0.011 | ||
| CMPK1 | cytidine monophosphate (UMP-CMP) kinase 1, cytosolic | 0.011 | ||
| CEBPA | CCAAT/enhancer binding protein (C/EBP), alpha | 0.011 | ||
| VIPR2 | vasoactive intestinal peptide receptor 2 | 0.011 | ||
| GAS1 | growth arrest-specific 1 | 0.011 | ||
| NODAL | nodal homolog (mouse) | 0.011 | Human | |
| ADRA1A | adrenergic, alpha-1A-, receptor | 0.011 | ||
| CYP2C8 | cytochrome P450, family 2, subfamily C, polypeptide 8 | 0.011 | ||
| RAMP2 | receptor (G protein-coupled) activity modifying protein 2 | 0.011 | ||
| TM4SF5 | transmembrane 4 L six family member 5 | 0.011 | ||
| ACVR1B | activin A receptor, type IB | 0.010 | ||
| ANKS3 | ankyrin repeat and sterile alpha motif domain containing 3 | 0.010 | ||
| CYP4F2 | cytochrome P450, family 4, subfamily F, polypeptide 2 | 0.010 | ||
| RIPK1 | receptor (TNFRSF)-interacting serine-threonine kinase 1 | 0.010 | ||
| ENDOU | endonuclease, polyU-specific | 0.010 | ||
| TACR3 | tachykinin receptor 3 | 0.010 | ||
| PRDX2 | peroxiredoxin 2 | 0.010 | ||
| NOX1 | NADPH oxidase 1 | 0.010 | ||
| SLC22A2 | solute carrier family 22 (organic cation transporter), member 2 | 0.010 | ||
| SLC17A4 | solute carrier family 17 (sodium phosphate), member 4 | 0.010 | ||
| ZFAND1 | zinc finger, AN1-type domain 1 | 0.010 | ||
| SPG20 | spastic paraplegia 20 (Troyer syndrome) | 0.010 | ||
| FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.010 | ||
| FXYD1 | FXYD domain containing ion transport regulator 1 | 0.010 | ||
| KCND3 | potassium voltage-gated channel, Shal-related subfamily, member 3 | 0.010 | ||
| ART1 | ADP-ribosyltransferase 1 | 0.010 | ||
| KCNC3 | potassium voltage-gated channel, Shaw-related subfamily, member 3 | 0.010 | ||
| LY6D | lymphocyte antigen 6 complex, locus D | 0.010 | ||
| FOXO3 | forkhead box O3 | 0.010 | ||
| HOXD12 | homeobox D12 | 0.010 | ||
| RAB11FIP4 | RAB11 family interacting protein 4 (class II) | 0.010 | ||
| FIBCD1 | fibrinogen C domain containing 1 | 0.010 | ||
| ESR2 | estrogen receptor 2 (ER beta) | 0.010 | ||
| PLA2G1B | phospholipase A2, group IB (pancreas) | 0.010 | ||
| STAG2 | stromal antigen 2 | 0.010 | ||
| ATP2B3 | ATPase, Ca++ transporting, plasma membrane 3 | 0.010 | ||
| HOXD1 | homeobox D1 | 0.010 | ||
| KCNQ1 | potassium voltage-gated channel, KQT-like subfamily, member 1 | 0.010 | ||
| RAPGEF2 | Rap guanine nucleotide exchange factor (GEF) 2 | 0.010 | ||
| ACRV1 | acrosomal vesicle protein 1 | 0.010 | ||
| KRT12 | keratin 12 | 0.010 | ||
| MID2 | midline 2 | 0.010 | ||
| MC2R | melanocortin 2 receptor (adrenocorticotropic hormone) | 0.010 | ||
| MRPS26 | mitochondrial ribosomal protein S26 | 0.010 | ||
| MLXIPL | MLX interacting protein-like | 0.010 |